Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 887, pseudogene (RNU6-887P) is a **pseudogene** corresponding to the U6 small nuclear RNA (snRNA) family, located on human chromosome 4[4]. U6 snRNA is a highly conserved non-coding RNA forming part of the U6 small nuclear ribonucleoprotein (snRNP) at the core of the spliceosome, a complex responsible for pre-mRNA splicing in the nucleus[1][5]. *Pseudogenes* such as RNU6-887P are generally non-functional genomic copies that lack protein-coding ability and typically do not contribute direct catalytic or binding functions in the cell[2]. While some pseudogenes may be transcribed and can potentially modulate gene regulation through various RNA-based mechanisms, the majority are not considered therapeutic targets, as is the case with RNU6-887P[2]. There are no known direct disease associations, drug interactions, mechanisms of action, biomarker uses, or safety concerns related to this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 887, pseudogene (RNU6-887P).